Newly Axial Silicon(IV) Phthalocyanine Photosensitizer: Design, Synthesis and Photochemical Properties

Year 2021, Volume: 17 Issue: 1, 11 - 16, 30.12.2020

Gülçin Ekineker , Hülya Yanık

https://doi.org/10.18466/cbayarfbe.821910

Cited By: 2

Abstract

Used as photosensitizer in photodynamic therapy, phthalocyanines exhibit their long wavelength absorption and the ability to produce high singlet oxygen for tumor destruction with 650 to 800 nm fluorescence.Phthalocyanines with their long wavelength absorption and fluorescence from 650 to 800 nm exhibit their ability to produce high singlet oxygen for the destruction of tumors. In this study, new axial substituted silicon(IV) phthalocyanine (4) was synthesized. Unsubstituted dichlorosilicon phthalocyanine was synthesized from 1,3-diiminoisoindoline via cyclotetramerization. The axial substitution reaction was carried out using dichlorosilicon(IV) phthalocyanine and excess of 2-methoxyethanol. Structural characterization of this new axial-substituted silicon(IV) phthalocyanine by IR, mass, and UV-Vis spectroscopy were performed. Photochemical properties were investigated for cancer therapy. In this study, we found that axial substituted silicon(IV) phthalocyanine (4) may be promising PDT agent.

Keywords

Axial,, silicon(IV) phthalocyanine,, photosensitizer,, Photodynamic Therapy,

References

• 1. Ekineker, G, Nguyen, C, Bayır, S, Dominguez Gil, S, İşci, Ü, Daurat, M, Godefroy, A, Raehm, L, Charnay, C, Oliviero, E, Ahsen, V, Gary-Bobo, M, Durand, J-O, and Dumoulin, F. 2019. Phthalocyanine-based mesoporous organosilica nanoparticles: NIR photodynamic efficiency and siRNA photochemical internalization, Chemical Communications; 55, 11619-11622.
• 2. Macdonald, I J, and Dougherty, T. J. 2001. Basic principles of photodynamic therapy, Journal of Porphyrins and Phthalocyanines 5, 105-129.
• 3. Tarhouni, M, Durand, D, Önal, E, Aggad, D, İşci, Ü, Ekineker, G, Brégier, F, Jamoussi, B, Sol, V, Gary-Bobo, M, and Dumoulin, F. 2018. Triphenylphosphonium-substituted phthalocyanine: Design, synthetic strategy, photoproperties and photodynamic activity, Journal of Porphyrins and Phthalocyanines; 22, 552-561.
• 4. Hopper, C. 2000. Photodynamic therapy: a clinical reality in the treatment of cancer, The lancet oncology; 1, 212-219.
• 5. Plaetzer, K, Krammer, B, Berlanda, J, Berr, F, and Kiesslich, T. 2009. Photophysics and photochemistry of photodynamic therapy: fundamental aspects, Lasers Med Sci; 24, 259-268.
• 6. Lo, P-C, Rodríguez-Morgade, M S, Pandey, R -K, Ng, D. K. P, Torres, T, and Dumoulin, F. 2020. The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer, Chemical Society Reviews.
• 7. Bartlett, M-A, Mark, K, and Sundermeyer, J. 2018. Synthesis, spectroscopy and singlet oxygen quantum yield of a non-aggregating hexadecamethyl-substituted phthalocyanine silicon (IV) derivative, Inorganic Chemistry Communications; 98, 41-43.
• 8. Barut, B, Demirbas, U, Ozel, A, and Kantekin, H. 2017. Novel water soluble morpholine substituted Zn(II) phthalocyanine: Synthesis, characterization, DNA/BSA binding, DNA photocleavage and topoisomerase I inhibition, International journal of biological macromolecules; 105, 499-508.
• 9. Skupin-Mrugalska, P, Szczolko, W, Gierlich, P, Konopka, K, Goslinski, T, Mielcarek, J and Düzgüneş, N. 2018. Physicochemical properties of liposome-incorporated 2-(morpholin-4-yl) ethoxy phthalocyanines and their photodynamic activity against oral cancer cells, Journal of Photochemistry and Photobiology A: Chemistry; 353, 445-457.
• 10. Baş, H, Biyiklioglu, Z. 2018. Synthesis and electropolymerization properties of axially disubstituted silicon phthalocyanines bearing carbazole units, Inorganica Chimica Acta; 483, 79-86.
• 11. Goksel, M, Biyiklioglu, Z, Durmus, M. 2017. The water soluble axially disubstituted silicon phthalocyanines: photophysicochemical properties and in vitro studies, Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry; 22, 953-967.
• 12. Bispo, M, Pereira, P. M. R, Setaro, F, Rodríguez-Morgade, M. S, Fernandes, R, Torres, T, Tomé, J. P. C. 2018. A Galactose Dendritic Silicon (IV) Phthalocyanine as a Photosensitizing Agent in Cancer Photodynamic Therapy, ChemPlusChem; 83, 855-860.
• 13. Baron, E. D, Malbasa, C. L, Santo-Domingo, D, Fu, P, Miller, J. D, Hanneman, K. K, Hsia, A. H, Oleinick, N. L, Colussi, V. C, Cooper, K. D. 2010. Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial, Lasers in surgery and medicine; 42, 728-735.
• 14. Armarego, W, Perrin, D. 1980. Purification of laboratory chemicals, Pergamon Press, Oxford 102, pp.102-103.
• 15. Yanık, H, Aydın, D, Durmuş, M, Ahsen, V. 2009. Peripheral and non-peripheral tetrasubstituted aluminium, gallium and indium phthalocyanines: Synthesis, photophysics and photochemistry, Journal of Photochemistry and Photobiology A: Chemistry; 206, 18-26.
• 16. Lowery, M. K, Starshak, A. J, Esposito, J. N, Krueger, P. C, Kenney, M. E. 1965. Dichloro (phthalocyanino) silicon, Inorganic Chemistry; 4, 128.
• 17. Răsădean, D. M, Gianga, T. M, Swan, A. H, Kociok-Köhn, G, Pantoş, G. D. 2018. Chiral Phthalocyanines through Axial Coordination, Organic letters; 20, 2645-2648.
• 18. Göksel, M, Durmuş, M, Atilla, D. 2017. Synthesis and photophysicochemical properties of a set of asymmetrical peptide conjugated zinc (II) phthalocyanines bearing different fluorophore units, Inorganica Chimica Acta; 456, 95-104.
• 19. Atmaca, G. Y, Dizman, C, Eren, T, Erdoğmuş, A. 2015. Novel axially carborane-cage substituted silicon phthalocyanine photosensitizer; synthesis, characterization and photophysicochemical properties, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy; 137, 244-249.